we are a publicly-traded holding company seeking to acquire and support exceptional businesses for the long term.
Company profile
Ticker
JANL
Exchange
Website
CEO
Dominique Schulte
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
JANEL WORLD TRADE LTD, WINE SYSTEMS DESIGN INC
SEC CIK
Corporate docs
Subsidiaries
Janel Group, Inc. • Indco, Inc. • Aves Labs, Inc. • Antibodies, Inc. • PhosphoSolutions, LLC • ImmunoChemistry Technologies, LLC • Expedited Logistics and Freight Services, LLC • ELFS Brokerage LLC • ECM Biosciences LLC • ImmunoBioScience Corporation ...
IRS number
861005291
JANL stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
16 Feb 24
10-Q
2024 Q1
Quarterly report
2 Feb 24
10-K
2023 FY
Annual report
8 Dec 23
8-K
Departure of Directors or Certain Officers
24 Aug 23
10-Q
2023 Q3
Quarterly report
4 Aug 23
8-K
Departure of Directors or Certain Officers
28 Jul 23
8-K
Departure of Directors or Certain Officers
2 Jun 23
10-Q
2023 Q2
Quarterly report
5 May 23
8-K
Entry into a Material Definitive Agreement
28 Apr 23
10-Q
2023 Q1
Quarterly report
3 Feb 23
Latest ownership filings
4
Kesteren Gerard van
29 Feb 24
3
Joseph Raymond Ferrara
22 Feb 24
4
Kesteren Gerard van
13 Feb 24
SC 13G
van Kesteren Foundation
2 Nov 23
4
Kesteren Gerard van
4 Oct 23
4
GREGORY B GRAVES
3 Oct 23
4
Kesteren Gerard van
3 Oct 23
4
GREGORY J MELSEN
3 Oct 23
4
John Joseph Gonzalez II
3 Oct 23
4
Ryan Karen Miller
3 Oct 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 24 | Kesteren Gerard van | Common Stock | Buy | Acquire P | No | No | 42 | 792 | 33.26 k | 20,000 |
23 Feb 24 | Kesteren Gerard van | Common Stock | Buy | Acquire P | No | No | 40.36 | 608 | 24.54 k | 19,208 |
20 Feb 24 | Kesteren Gerard van | Common Stock | Buy | Acquire P | No | No | 38.37 | 100 | 3.84 k | 18,600 |
16 Feb 24 | Kesteren Gerard van | Common Stock | Buy | Acquire P | No | No | 34.18 | 1,500 | 51.27 k | 18,500 |
9 Feb 24 | Kesteren Gerard van | Common Stock | Buy | Acquire P | No | No | 32 | 1,880 | 60.16 k | 17,000 |
9 Feb 24 | Kesteren Gerard van | Common Stock | Buy | Acquire P | No | No | 31.99 | 120 | 3.84 k | 15,120 |
2 Oct 23 | Ryan Karen Miller | Stock Option Common Stock | Grant | Acquire A | No | No | 28.25 | 2,500 | 70.63 k | 2,500 |
2 Oct 23 | Gonzalez John Joseph II | Stock Option Common Stock | Grant | Acquire A | No | No | 28.25 | 2,500 | 70.63 k | 2,500 |